Navigation Links
Exercise Better Than Ergonomics to Treat Upper-Body Work Injuries

Many conservative methods used to treat work-related complaints of the upper body have only limited effectiveness, according to an updated systematic review by Arianne Verhagen, Ph.D., and her colleagues in the Netherlands. Exercise, however, emerged as “a very good thing to do,” she said.//

Yet, “conservative interventions such as physiotherapy and ergonomic adjustments play a major role in the treatment of most work-related complaints of the arm, neck or shoulder,” said Verhagen, a physical therapist and epidemiologist at the Erasmus University Medical Center, Rotterdam.

As for expensive ergonomic equipment like special keyboards and office furniture, little scientific evidence currently exists to support their use.

The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates research in all aspects of health care. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing trials on a topic.

Verhagen updated a review published in 2003, which had included 15 trials. She added six new trials for a total of 2,110 adult participants. Most were industrial workers or hospital staff who suffered with chronic complaints varying between three and 12 months. Workers with inflammatory or neurological diseases were not included.

The randomized and nonrandomized controlled trials evaluated more than 25 conservative interventions including exercises, relaxation, ultrasound, biofeedback, myofeedback and workplace adjustments.

Verhagen said she is not surprised that exercise appeared most helpful to people suffering from chronic complaints of the arm, neck or shoulder.

“I am an evidence-based person, and exercise seems to be the best intervention from this review,” said Verhagen. “That’s what I do. When I treat patients, I know that
'"/>




Page: 1 2 3

Related medicine news :

1. Exercises reduce risks of cancers
2. Exercise lowers Risk of Ovarian Cancer
3. Exercise is necessary in daily life
4. Exercise for patients with cancer
5. Exercise therapy for fibromyalgia
6. Exercise has a undeniable effect on cholesterol
7. Exercise with music aids with lung disorders
8. Exercise helps with leg cramps
9. Exercise helps people with cramping leg pain
10. Kids not getting enough Physical Exercise
11. Moderate Exercise may not help prevent Heart Disease

Post Your Comments:
(Date:11/9/2009)... Study in mice reports success with drugs that in...lthDay News) -- Two drugs used to treat breast can... mice, according to a new study. , The drugs al...vagina, and prevented the onset of cancer in mice ...drug fulvestrant and the breast cancer/osteoporosi...
(Date:11/9/2009)... Plavix helped men and women almost equally, stud...News) -- The widely used clot-dissolving drug Plav...in men, an analysis of major clinical trials has f...confident in treating both men and women with this... director of cardiovascular thrombosis at New York...
(Date:11/9/2009)... , Networking is everybod...s it means Money. StaffingClub.com enables Recruit...of contacts to connect, share, communicate and clo... Seekers to post their profiles and network with r...mber 9, 2009 -- Current Job Market forces everyone...
(Date:11/9/2009)... Therapy to improve letter formation could boost ... Nov. 9 (HealthDay News) -- Autistic children are ...g trouble forming letters, than those without auti...8 children, aged 8 to 13. Half of the study partic...e children scored within the normal range for perc...
(Date:11/9/2009)... Rabbits implanted with new cells regained sexual...v. 9 (HealthDay News) -- Researchers were able to ...nises by growing new penile tissue in the lab and ...human application is a ways off, researchers say t... erectile dysfunction in men. , "We were able t...
Breaking Medicine News(10 mins):Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3
...ffected the dental health of the expectant mother....ammations can lead to a condition of preeclampsia ...ic dental inflammation and periodontal infection, ...moking, etc. The basic reason for setting in the d...
...nic, progressive disorder where there is a loss of...rug // alendronate if taken daily for 10 years can...ugs, such as alendronate, have been used for years...he drug for the next two years. Then for the next ...
...that fetal cell transplantation for patients with ...id of their medications altogether.// Parkinso... impairs mobility. Patients with Parkinson’s lack ...st dopamine-producing cells to help restore moveme...
...ommon sleep disorder leaves nearly millions groggy...is that // the tricks they do to get to sleep may ...alists say as we age, biological changes gradually...to do is to cut out caffeine after noon and to ski...
... recent study researchers say annual flu vaccines ... on // hospitalizations, respiratory tract infecti...pecially true for children who received an inactiv...r children under age 2 who received the inactivate...
...Society's 140th Midwinter Meeting that begins in U...orld over can take a peek to some very innovative ...isplay there. The convention is also one of the la...s that automatically dispenses toothpaste, and a c...
Other Medicine News:
(Date:11/10/2009)...ass. and TOKYO, Nov. 10 Ironwood P...y announced that they have entered into an agreeme...and commercialize the investigational compound lin...es, Taiwan, and Thailand. Linaclotide is currently...tes for the treatment of irritable bowel syndrome ...
(Date:11/9/2009)...Ala., Nov. 9 Surgical Ca... host an investor conference call at 11:00 a.m. Ea...s its 2009 third quarter operating results. A 30-... following the conclusion of the conference call. ...h/20080812/CLTU111LOGO ) ,, Please go to SCA...
(Date:11/9/2009)...s., Nov. 9 Hologic, Inc....ing developer, manufacturer and supplier of premiu...l products dedicated to serving the healthcare nee...ourth quarter and fiscal year ended September 26, ...rd of Directors has promoted Robert Cascella to Ch...
Breaking Medicine Technology:Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 1VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 5nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 1nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 2nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 3nCircle and HITRUST Partner to Deliver Innovative SaaS Offering to Secure Healthcare Information 48586 4ReStart DC Launches Life Saving Public Access Defibrillation Program 48583 1ReStart DC Launches Life Saving Public Access Defibrillation Program 48583 2ReStart DC Launches Life Saving Public Access Defibrillation Program 48583 3
... 2007 - ACADIA Pharmaceuticals,Inc. (Nasdaq:ACAD) ... Phase II schizophrenia co-therapy trial with ACP-...erse agonist. The trial,evaluated ACP-103 co-thera...ommonly prescribed atypical antipsychotic drug, or.... The co-therapy,arms with ACP-103 demonstrated st...
...ire-FirstCall/ -- La Jolla,Pharmaceutical Company ... data for the Phase 3 trial of Riquent(R) (abetimu...rythematosus,("lupus" or "SLE"). The updated analy...s a definitive and significant dose response,betwe...compared,with placebo (p=0.0001). These interim da...
Other Medicine Technology:Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 2Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 3Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 4Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 5Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 6La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6
Castroviejo Suture Forceps
deJuan Pic Forceps - Black
Thomas Long Subretinal Forceps
Olk Membrane Peeler
Medicine Products: